Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The devices bring new benefits to patients with heart rhythm disorders, including a patient-preferred design without compromising battery longevity and MRI compatibility.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it introduced first-of-its-kind mobile Intensive Care Units (ICUs) in India. Designed to meet the critical-care requirements of patients, each prefabricated ICU has a capacity of nine beds.
The 2020-2 Connecting Europe Facility (CEF) Telecom call for proposals is now open, making €36 million available to stimulate and support the deployment of European Digital Service Infrastructures (DSIs) in eight areas. CEF Telecom funding supports projects of common interest that improve the daily life of citizens, businesses and public administrations and contribute to the development of a Digital Single Market by deploying European digital infrastructures across the EU.
16 - 19 November 2020, Düsseldorf, Germany.
The Highland Marketing advisory board has been discussing the impact of the coronavirus outbreak on the deployment of health tech in the NHS.
At its March meeting, which took place just after UK prime minister Boris Johnson instructed people to "stay at home", members noted the rapid roll-out of remote working and virtual consultation tools, which are unlikely to be abandoned once the emergency is over.